Schroder Income Growth Fund plc
|GlaxoSmithKline PLC||13.91 %|
|BP PLC||10.79 %|
|Lloyds Banking Group PLC||10.31 %|
|Royal Dutch Shell PLC B||10.21 %|
|BAE Systems PLC||8.34 %|
|AstraZeneca PLC||8.24 %|
|British American Tobacco PLC||8.18 %|
|Legal & General Group PLC||7.52 %|
|Tesco PLC||7.31 %|
|G4S PLC||6.71 %|
|United Kingdom||98.66 %|
|Financial Services||18.19 %|
|Consumer Cyclical||15.12 %|
|Consumer Defensive||10.47 %|
|Communication Services||9.80 %|
|Basic materials||8.54 %|
Sue Noffke is a UK Equity Fund Manager at Schroders, and a founding member of the Prime UK Equity team established in 2006. She is co-fund manager of the Schroder Prime UK Equity Fund and fund manager of the Schroder Income Growth Fund plc. Sue has managed UK equity portfolios for institutional clients since 1993. She joined Schroders in 1989 and is based in London. Sue was an analyst at Schroders from 1989 to 1993, with responsibilities for insurance, tobacco and retail sectors in the UK market. Qualifications: Honorary Doctorate Degree from Aston University; BSc in Business Administration and Biochemistry from Aston University.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.